A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Fonterra goes hunting in the South Island for organic milk
Primary Sector

Fonterra goes hunting in the South Island for organic milk

Its main rival is pulling out of organics down south.

Riley Kennedy 22 Jan 2026
Another Rockit apple orchard hits trouble
Primary Sector

Another Rockit apple orchard hits trouble

Another partnership growing trademarked Rockit apples has gone into voluntary administration.Rockit Orchard No.2 Limited Partnership and ROP2 General Partner appointed BDO as administrators last month. The first creditors’ meeting was held on Jan 12.In October, BDO were appointed...

Staff reporters 21 Jan 2026
Director looks to pull Bains Hort Group back out of liquidation
Primary Sector

Director looks to pull Bains Hort Group back out of liquidation

It has been allowed to operate its orchards ahead of this year's harvest.

Riley Kennedy 21 Jan 2026
Sluggish Chinese birth rate slams a2 Milk's share price
Primary Sector

Sluggish Chinese birth rate slams a2 Milk's share price

Forsyth Barr's Matt Montgomerie said rates were materially weaker than expected. 

Riley Kennedy 20 Jan 2026